The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated Analyses
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this reason, tadalafil has less than 0.1% occurrence of vision abnormalities (Brock et al 2002; Carson et al 2004a).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Brock et al 2002
In the citing paper
“The onset of action of tadalafil may occur in as early as 15 minutes of dosing, although successful erections occur in fewer than 40% of men at this time point (Brock et al 2002; Porst et al 2003).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Brock et al 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
(1999) · doi:10.1016/s0090-4295(99)00099-0 · Cited by 1,051
Research works printed but not linked: 9
- McKinlay, 2000, The worldwide prevalence and epidemiology of erectile dysfunction, Int J Impot Res, 12, S6, 10.1038/sj.ijir.3900567 · DOI · Paper page
- 1992, Impotence, NIH Consens Statement, 10, 1
- Mobley, 1998, When patients request the impotence pill, Postgrad Med, 104, 55, 10.3810/pgm.1998.08.561 · DOI
- Lincoln, 1989, Cyclic GMP and mechanisms of vasodilation, Pharmacol Ther, 41, 479, 10.1016/0163-7258(89)90127-7 · DOI · Paper page
- Carvajal, 2000, Molecular mechanism of cGMP-mediated smooth muscle relaxation, J Cell Physiol, 184, 409, 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K · DOI
- Ignarro, 1990, Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle, Biochem Biophys Res Commun, 170, 843, 10.1016/0006-291X(90)92168-Y · DOI · Paper page
- Padma-Nathan, 2001, On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction, Int J Impot Res, 13, 2, 10.1038/sj.ijir.3900631 · DOI
- Rosen, 1997, The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0 · DOI · Paper page
- Hanson-Divers, 1998, Health outcomes variables important to patients in the treatment of erectile dysfunction, J Urol, 159, 1541, 10.1097/00005392-199805000-00037 · DOI
Cited by
Erectile dysfunction: AUA guideline
Burnett, A. L., Nehra, A., Breau, R. H., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J., Khera, M., McVary, K. T., Miner, M. M., et al. (2018) · Journal of Urology · doi:10.1016/j.juro.2018.05.004 · Cited by 949
Rosen, R. C., Allen, K. R., Ni, X., & Araujo, A. B. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.053 · Cited by 460
Porst, H., Padma-Nathan, H., Giuliano, F., Anglin, G., Varanese, L., & Rosen, R. (2003) · Urology · doi:10.1016/s0090-4295(03)00359-5 · Cited by 320
Self-citationTadalafil pharmacokinetics in healthy subjects
Forgue, S. T., Patterson, B. E., Bedding, A. W., Payne, C. D., Phillips, D. L., Wrishko, R. E., & Mitchell, M. I. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02553.x · Cited by 284
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Seftel, A. D. (2004) · Clinical Cardiology · doi:10.1002/clc.4960271305 · Cited by 79
Corona, G., Rastrelli, G., Burri, A., Jannini, E. A., & Maggi, M. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1130126 · Cited by 71
The role of the sexual partner in managing erectile dysfunction
Li, H., Gao, T., & Wang, R. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2015.315 · Cited by 65
Treatment Options for Erectile Dysfunction
Brant, W. O., Bella, A. J., & Lue, T. F. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.02.001 · Cited by 51
Role of sGC-dependent NO signalling and myocardial infarction risk
Wobst, J., Kessler, T., Dang, T. A., Erdmann, J., & Schunkert, H. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1265-3 · Cited by 28
Tadalafil: a novel treatment for erectile dysfunction
GIULIANO, F. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90049-0 · Cited by 21
Erectile dysfunction and its pharmacology: An overview
Patnaik, S. K., Polimati, H., & Pragada, R. R. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i2.15183 · Cited by 3
“Tadalafil Tadalafil is effective from 30 minutes after administration, but its peak efficacy is expected in about 2 hrs [19].”
Background
Metadata
- Authors
- Brock, G. B., McMahon, C. G., Chen, K. K., Costigan, T., Shen, W., Watkins, V., Anglin, G., & Whitaker, S.
- Affiliations
- From the Department of Surgery, Division of Urology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada, the Australian Centre for Sexual Health, St. Luke’s Hospital Complex, Sydney, New South Wales, Australia, Taipei Veterans General Hospital, Taipei, Taiwan, Eli Lilly and Company, Indianapolis, Indiana, and ICOS Corporation, Bothell, Washington
- Venue
- Journal of Urology
- Published
- 2002-10
- Volume
- 168
- Issue
- 4 Part 1
- Pages
- 1332-1336
- ISSN
- 0022-5347
- 1527-3792
- Cited by
- 421
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
